{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:35:16Z","timestamp":1792676116618,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1124\/jpet.114.220798","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T03:12:28Z","timestamp":1416971548000},"page":"274-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity"],"prefix":"10.1016","volume":"352","author":[{"given":"Dan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Michie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander John","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Hillgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori Takedai","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Peltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.220798_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/tx8004086","article-title":"Predicting circulating human metabolites: how good are we?","volume":"22","author":"Anderson","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.114.220798_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc, B"},{"key":"10.1124\/jpet.114.220798_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/bj2800373","article-title":"Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats","volume":"280","author":"Dueland","year":"1991","journal-title":"Biochem J"},{"key":"10.1124\/jpet.114.220798_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.114.220798_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(02)00107-1","article-title":"Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan","volume":"37","author":"Fouassier","year":"2002","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.114.220798_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.220798_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/FPC.0b013e32835cb2c7","article-title":"Human pharmacogenetic analysis in chimeric mice with \u2018humanized livers.\u2019","volume":"23","author":"Hu","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.114.220798_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09031936.00138706","article-title":"Results of European post-marketing surveillance of bosentan in pulmonary hypertension","volume":"30","author":"Humbert","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.114.220798_bib9","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1124\/jpet.114.220798_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/tx800432c","article-title":"Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development","volume":"22","author":"Leclercq","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.114.220798_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/dmd.108.026260","article-title":"In silico prediction of biliary excretion of drugs in rats based on physicochemical properties","volume":"38","author":"Luo","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.114.220798_bib12","series-title":"Review of the Fialuridine (FIAU) Clinical Trials","author":"Manning","year":"1995"},{"key":"10.1124\/jpet.114.220798_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdd.527","article-title":"Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2","volume":"28","author":"Mano","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.114.220798_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.220798_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/jsre.1996.0345","article-title":"Bile acid synthesis and biliary hydrophobicity during obstructive jaundice in rats","volume":"65","author":"Naito","year":"1996","journal-title":"J Surg Res"},{"key":"10.1124\/jpet.114.220798_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.112.198697","article-title":"Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction","volume":"344","author":"Nishimura","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220798_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/toxsci\/kfm041","article-title":"Humanization of excretory pathway in chimeric mice with humanized liver","volume":"97","author":"Okumura","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.114.220798_bib18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.114.220798_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2013.03.005","article-title":"Can \u2018humanized\u2019 mice improve drug development in the 21st century?","volume":"34","author":"Peltz","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.114.220798_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.220798_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/jpet.114.220798_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/oxfordjournals.jbchem.a122346","article-title":"Effect of bile duct ligation on bile acid and cholesterol metabolism in rats","volume":"103","author":"Takita","year":"1988","journal-title":"J Biochem"},{"key":"10.1124\/jpet.114.220798_bib23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/tx900213j","article-title":"A holistic strategy for characterizing the safety of metabolites through drug discovery and development","volume":"22","author":"Walker","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.114.220798_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.21095","article-title":"Drug-induced liver injury: summary of a single topic clinical research conference","volume":"43","author":"Watkins","year":"2006","journal-title":"Hepatology"},{"key":"10.1124\/jpet.114.220798_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/0091270008319329","article-title":"PhRMA white paper on ADME pharmacogenomics","volume":"48","author":"Williams","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.114.220798_bib26","doi-asserted-by":"crossref","first-page":"e1001628","DOI":"10.1371\/journal.pmed.1001628","article-title":"Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing","volume":"11","author":"Xu","year":"2014","journal-title":"PLoS Med"},{"key":"10.1124\/jpet.114.220798_bib27","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1124\/mol.106.026955","article-title":"The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice","volume":"70","author":"Zamek-Gliszczynski","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220798_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","article-title":"Effect of bile duct ligation on bile acid composition in mouse serum and liver","volume":"32","author":"Zhang","year":"2012","journal-title":"Liver Int"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.220798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:57:24Z","timestamp":1739987844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524189409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0022356524189409"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.220798","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.220798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}